Pasithea Therapeutics (KTTA) stock Forecast for 2022 – 2026
Last update: 05-19-2022, 17:20Sector: Healthcare
The share price of Pasithea Therapeutics Corp. (KTTA) now
What analysts predict:: $3
52-week high/low: $5.6 / $0.86
50/200 Day Moving Average: $1.205 / $1.875
This figure corresponds to the average price over the previous 50/200 days. For Pasithea Therapeutics stocks, the 50-day moving average is the resistance level today.
For Pasithea Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Pasithea Therapeutics Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Pasithea Therapeutics stock price in 2022, 2023, 2024, 2025, 2026. How much will one Pasithea Therapeutics share be worth in 2022 - 2026?
When should I take profit in Pasithea Therapeutics stock? When should I record a loss on Pasithea Therapeutics stock? What are analysts' forecasts for Pasithea Therapeutics stock? What is the future of Pasithea Therapeutics stock?
We forecast Pasithea Therapeutics stock performance using neural networks based on historical data on Pasithea Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Pasithea Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Pasithea Therapeutics shares. This happens once a day.
Historical and forecast chart of Pasithea Therapeutics stock
The chart below shows the historical price of Pasithea Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Pasithea Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Pasithea Therapeutics daily forecast for a month
Pasithea Therapeutics Daily Price Targets
Pasithea Therapeutics Stock Forecast 05-21-2022.
Pessimistic target level: 0.89
Optimistic target level: 0.95
Pasithea Therapeutics Stock Forecast 05-22-2022.
Pessimistic target level: 0.92
Optimistic target level: 1.00
Pasithea Therapeutics Stock Forecast 05-23-2022.
Pessimistic target level: 0.86
Optimistic target level: 0.91
Pasithea Therapeutics Stock Forecast 05-24-2022.
Pessimistic target level: 0.84
Optimistic target level: 0.92
Pasithea Therapeutics Stock Forecast 05-25-2022.
Pessimistic target level: 0.90
Optimistic target level: 0.97
Pasithea Therapeutics Stock Forecast 05-26-2022.
Pessimistic target level: 0.95
Optimistic target level: 0.99
KTTA (KTTA) Monthly Stock Prediction for 2022
Pasithea Therapeutics forecast for this year
Pasithea Therapeutics Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $0.973694. Pessimistic: $0.83. Optimistic: $1.07
Pasithea Therapeutics Stock Prediction for Jul 2022
An uptrend is forecast for this month with an optimal target price of $1.06162. Pessimistic: $0.99. Optimistic: $1.12
Pasithea Therapeutics Stock Prediction for Aug 2022
An uptrend is forecast for this month with an optimal target price of $1.16417. Pessimistic: $0.99. Optimistic: $1.24
Pasithea Therapeutics Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $0.995483. Pessimistic: $0.94. Optimistic: $1.13
Pasithea Therapeutics Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $1.07492. Pessimistic: $0.90. Optimistic: $1.17
Pasithea Therapeutics Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $1.09975. Pessimistic: $1.02. Optimistic: $1.23
Pasithea Therapeutics Stock Prediction for Dec 2022
An downtrend is forecast for this month with an optimal target price of $1.01892. Pessimistic: $0.88. Optimistic: $1.07
Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2023
Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2024
Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2025
Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2026
Pasithea Therapeutics information and performance
Pasithea specializes in the discovery and development of new drugs for the treatment of psychiatric and neurological disorders. The company does not currently have a leading candidate drug in development. In the 24 months following its IPO, the company plans to discover three leading candidate compounds targeting the immune system’s link to certain mental disorders. An additional Pasithea business is to open depression clinics in the UK and the US, where doctors will administer ketamine intravenously to patients when indicated.
Pasithea Therapeutics Address
2110 NARCISSUS CT, VENICE, CA, US
Market Capitalization: 20 104 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: - $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: -
Enterprise Value (EV) /Revenue
EV To EBITDA: 14.6
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 22858400
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.